Anthracenes
eMolecules 2,3-Dibromoanthracene | 117820-97-0 | MFCD30497387 | 50mg
Toronto Research Chemicals | 2,3-Dibromoanthracene | 50mg | 483399302 | D422995 | | 117820-97-0 | MFCD30497387 | 336.026 | C14H8Br2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules Target Molecule TAK-779 5mg 517682755 T7499 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
Target Molecule TAK-779 5mg 517682755 T7499 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
Sigma Aldrich Fine Chemicals Biosciences Anthracene suitable for scintillation, >=99.0% (GC) | 120-12-7 | MFCD00001240 | 25G
Anthracene suitable for scintillation, >=99.0% (GC) | Purity: >=99.0% (GC) | Mol Wt: 178.23 | 120-12-7 | MFCD00001240 | 25G
Sigma Aldrich Fine Chemicals Biosciences 9-Bromoanthracene 94% | Purity: 94% | Mol Wt: 257.13 | 1564-64-3 | MFCD00001243 | 25G
9-Bromoanthracene 94% | Purity: 94% | Mol Wt: 257.13 | 1564-64-3 | MFCD00001243 | 25G
eMolecules Ambeed / 2-Acetylanthracene / 250mg / 552749437 / A649641 / / 10210-32-9 / MFCD00156727 / 220.271 / C16H12O
Ambeed / 2-Acetylanthracene / 250mg / 552749437 / A649641 / / 10210-32-9 / MFCD00156727 / 220.271 / C16H12O
![eMolecules Ambeed / (2R3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-ethyl-23-dihydrobenzo[d][13]oxaphosphole / 100mg / 521452696 / A1207655 / / 2565792-21-2 / [null] / 398.486 / C27H27OP](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502453644.PNG-250.jpg)
eMolecules Ambeed / (2R3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-ethyl-23-dihydrobenzo[d][13]oxaphosphole / 100mg / 521452696 / A1207655 / / 2565792-21-2 / [null] / 398.486 / C27H27OP
Ambeed / (2R3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-ethyl-23-dihydrobenzo[d][13]oxaphosphole / 100mg / 521452696 / A1207655 / / 2565792-21-2 / [null] / 398.486 / C27H27OP
![Medchemexpress LLC (2S)-N-[7-chloro-6-[4-[(3R,4R)-4-hydroxy-3-methyloxolan-3-yl]piperazin-1-yl]isoquinolin-3-yl]-6-o... | 2769107-89-1 | 99.7% | 501.02 g·mol⁻1 | C26H33ClN4O4 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000288091.png-250.jpg)
Medchemexpress LLC (2S)-N-[7-chloro-6-[4-[(3R,4R)-4-hydroxy-3-methyloxolan-3-yl]piperazin-1-yl]isoquinolin-3-yl]-6-o... | 2769107-89-1 | 99.7% | 501.02 g·mol⁻1 | C26H33ClN4O4 | 10 MG
MK-1468 is an orally active, selective, blood-brain barrier-permeable inhibitor of leucine-rich repeat kinase 2 (LRRK2) used in preclinical research of Parkinson's disease and LRRK2-related pathways.
- Orally active and brain-penetrant LRRK2 inhibitor suitable for in vivo and in vitro studies.
- High purity (≈99.7%) for research-grade experiments.
- Molecular weight 501.02 g·mol⁻1 and formula C26H33ClN4O4.
- Available in small-scale quantities for dosing and assay optimization.
- Store powder at -20°C; solutions stable at -80°C for 6 months.
eMolecules Ambeed TAK-779 25mg 832562838 A734428 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
Ambeed TAK-779 25mg 832562838 A734428 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
Apexbio Technology LLC A 779 159432-28-7 1mg
A 779 (CAS 159432-28-7) is a selective antagonist of the angiotensin-(1-7)/Mas receptor By competitively inhibiting angiotensin-(1-7) a bioactive peptide of the renin-angiotensin system (RAS) involved in cardiovascular and renal homeostasis A 779 enables detailed study of Mas receptor-mediated signaling In vivo A 779 blocks the antidiuretic and pressor effects of angiotensin-(1-7) in rats and modulates the response to bradykinin potentiation by ACE inhibition It has been used to explore interactions among angiotensin receptors and the role of Mas signaling in cardiovascular and renal physiology